2 unknown, 1 completed, 1 recruiting. 4 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Unknown 2, Completed 1, Recruiting 1 |
| Phase 2 | 2 | Unknown 2 |
Follow Prevention & Control: new trials by email Literature Review of Prevention & Control trials Research Report on Prevention & Control
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis Rosuvastatin 20 Mg Oral Tablet, Colchicine 0.5 MG Oral Tablet Once Daily, Placebo - Coronary Artery Disease Risk Factors Multiple, Coronary Artery Disease Progression | Phase 3 | Recruiting | Duke University | 1500 | 2026-07-21 | 2026-11-10 |
| Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM) Hydroxychloroquine Only Product in Oral Dose Form - Sars-CoV2, Coronavirus Infection | Phase 2 / Phase 3 | Unknown | University of Malaga | 1930 | 2020-09-01 | 2020-09-29 |
| Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease Rivaroxaban (Xarelto, BAY59-7939), Aspirin, Aspirin placebo - Prevention & Control | Phase 3 | Completed | Bayer | 27395 | 2013-02-28 | 2022-11-28 |
| Study of Trimethoprim/Sulfamethoxazole as PCP Prophylaxis in CTD Patients Trimethoprim/Sulfamethoxazole - Pneumonia, Pneumocystis, Prevention & Control | Phase 2 / Phase 3 | Unknown | Peking Union Medical College Hospital | 80 | 2012-08-01 | 2012-12-11 |
Angina Pectoris (1) · COVID-19 (1) · Coronary Artery Disease (1) · Coronavirus Infections (1) · Heart Diseases (1) · Myocardial Infarction (1) · Peripheral Arterial Disease (1) · Pneumonia, Pneumocystis (1) · Stroke (1)
Infections (2) · Lung Diseases (2) · Pneumonia (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Atherosclerosis (1) · Bacterial Infections and Mycoses (1) · Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Chest Pain (1) · Coronary Disease (1)
Aspirin (1) · Colchicine (1) · Dosage Forms (1) · Pantoprazole (1) · Rivaroxaban (1) · Rosuvastatin Calcium (1) · Tablets (1) · Trimethoprim, Sulfamethoxazole Drug Combination (1)
Bayer (1) · Duke University (1) · Peking Union Medical College Hospital (1) · University of Malaga (1)
China (2) · United States (2) · Argentina (1) · Australia (1) · Belgium (1) · Brazil (1) · Canada (1) · Chile (1) · Colombia (1) · Czechia (1) · Denmark (1) · Ecuador (1) · Finland (1) · France (1) · Germany (1)
Fengchun Zhang, MD (1) · Juan C Morilla-Herrera, PhD (1)
PMID 28754388, PMID 28844176, PMID 28844192, PMID 29132877, PMID 29132879, PMID 29132880, PMID 29186454, PMID 29346127, PMID 29372976, PMID 29540326, PMID 29661947, PMID 29945212, PMID 30058959, PMID 30213508, PMID 30220379, PMID 30354448, PMID 30417662, PMID 30538057, PMID 30654882, PMID 30667279, PMID 30702997, PMID 30916315, PMID 31054846, PMID 31072566, PMID 31144674, PMID 31146821, PMID 31152740, PMID 31163978, PMID 31248548, PMID 31248549, PMID 31321405, PMID 31358978, PMID 31504399, PMID 31510769, PMID 31524941, PMID 31537259, PMID 31615291, PMID 31715433, PMID 31807773, PMID 32178526, PMID 32223318, PMID 32289159, PMID 32436455, PMID 32651298, PMID 32951537, PMID 32997098, PMID 33538248, PMID 33957178, PMID 34021038, PMID 34132753
UG3HL181434 (1)